<--- Back to Details
First PageDocument Content
Titan Pharmaceuticals / Forward-looking statement / Form 10-K / Titan Company / Business / Economy
Date: 2016-08-22 18:06:43
Titan Pharmaceuticals
Forward-looking statement
Form 10-K
Titan Company
Business
Economy

MANAGEMENT TEAM COMPANY OVERVIEW Marc Rubin, MD

Add to Reading List

Source URL: c.eqcdn.com

Download Document from Source Website

File Size: 32,51 KB

Share Document on Facebook

Similar Documents

Neurochemistry / Chemistry / Drug rehabilitation / Morphinans / Nervous system / Opioid antagonists / Euphoriants / Alcohols / Buprenorphine / Opioid use disorder / Opioid / Methadone

TITAN PHARMACEUTICALS CORPORATE PRESENTATION Ÿ SUNIL BHONSLE Ÿ JUNE 2016 © 2016 TITAN PHARMACEUTICALS INC. Ÿ NASDAQ:TTNP

DocID: 1rsmr - View Document

Nuclear weapons of the United States / Neurochemistry / Drug rehabilitation / Morphinans / Pharmaceuticals policy / Lockheed Martin / Chemistry / Titan Pharmaceuticals / Business / Titan / Pharmaceutical industry in China / Buprenorphine

May 10, 2016 Titan Pharmaceuticals Reports First Quarter 2016 Financial Results Titan Management Team to Host Conference Call Today at 4:15 P.M. EDT / 1:15 P.M. PDT

DocID: 1qU4O - View Document

Titan Pharmaceuticals / Forward-looking statement / Form 10-K / Titan Company / Business / Economy

MANAGEMENT TEAM COMPANY OVERVIEW Marc Rubin, MD

DocID: 1qOxW - View Document

Drug rehabilitation / Morphinans / Opioid antagonists / Euphoriants / Alcohols / Buprenorphine / Opioid use disorder / Opioid / Methadone / Addiction

TITAN PHARMACEUTICALS CORPORATE PRESENTATION Ÿ SUNIL BHONSLE Ÿ JUNE 2016 © 2016 TITAN PHARMACEUTICALS INC. Ÿ NASDAQ:TTNP

DocID: 1pFjn - View Document

Morphinans / Drug rehabilitation / Opioid antagonists / Alcohols / Euphoriants / Buprenorphine / Opioid use disorder / Opioid / Methadone / Addiction / Naloxone / Titan Pharmaceuticals

Sunil Bhonsle Apr 2015 Corporate Presentation

DocID: 1p6fZ - View Document